HHS Provides More COVID-19 Relief Funds to Healthcare Providers
The Department of Health and Human Services (HHS) announced more than $413 million in Provider Relief Fund (PRF) payments to more than 3,600 providers across the country.
How the No Surprises Act Protects Consumers
New federal protections shield millions of consumers from surprise medical bills, which are unexpected bills from out-of-network providers, out-of-network facilities or out-of-network air ambulance providers.
Plasma Prekallikrein Inhibition by Antisense Oligonucleotide Reduces Hereditary Angioedema Disease Burden
An investigational antisense oligo-nucleotide (donidalorsen) that acts by degrading plasma prekallikrein messenger RNA was evaluated in patients with hereditary angioedema (HAE) and C1 inhibitor deficiency to assess whether this agent can reduce the frequency of angioedema attacks and the burden of disease.
IVIG Plus Glucocorticoids Superior to IVIG Alone for MIS-C Associated with COVID-19: Review and Meta-Analysis
A new systematic review and meta-analysis conducted by U.S. and Nepalese collaborators supports the use of IVIG with glucocorticoids compared to IVIG alone.
Scientists Are Developing Cheaper, Patent-Free and Easier-to-Make COVID Vaccine
Researchers at the Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine are developing a COVID-19 vaccine using a conventional method that will make the production and distribution cheaper and more accessible.
New Drugs Approved by FDA to Treat Eczema
AbbVie’s Rinvoq and Pfizer’s Cibinqo have been approved by the U.S. Food and Drug Administration (FDA) to treat moderate-to-severe atopic dermatitis.
Virus Identified as Cause of Multiple Sclerosis
A new study shows the Epstein-Barr virus (EBV) is essential for the development of multiple sclerosis (MS).
FDA Approves Argenx’s Vyvgart to Treat MG
The U.S. Food and Drug Administration (FDA) has approved Vyvgart (efgartigi-mod) to treat generalized myasthenia gravis (gMG) in adults who test positive for the anti-acetylcholine receptor (AChR) antibody.
Two Major Changes in Medicare in 2022
The COVID-19 pandemic highlighted gaps the healthcare system. Two improvements to Medicare in 2022 seek to give people greater access to telehealth and other care delivery options.
Researchers at Emory University Awarded Grant to Pursue a Cure for HIV
An Emory University-led research collaboration has been awarded a five-year $23.8 million grant from the National Institutes of Health (NIH) to fast-track research to cure HIV infection or put it in permanent remission.
